AlphaYouGC
Fund 13F filing
GLENVIEW CAPITAL MANAGEMENT, LLC cut $321M of Teva Pharmaceutical Industries Ltd (TEVA) stock
GLENVIEW CAPITAL MANAGEMENT, LLC cut $321M of Teva Pharmaceutical Industries Ltd (TEVA) stock in the quarter ending Mar 31, 2026, per a 13F filed May 15, 2026.
A 13F shows holdings at quarter end, so the exact trade dates are not disclosed.
- Disclosed
- May 15, 2026
- Quarter end
- Mar 31, 2026
- Source
- SEC Form 13F
More TEVA insider and Congress trades
From a public SEC Form 13F, linked above. Not investment advice, and not a recommendation to buy or sell.